Viridian Therapeutics, Inc./DE
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $131.3M
Liabilities Breakdown FY2020
Total Liabilities: $11.2M
Asset Breakdown
Total Assets: $131.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $45.9M | 35.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $309.0K | 0.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $85.0M | 64.8% |
Liabilities Breakdown
Total Liabilities: $11.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $670.0K | 6.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $10.5M | 94.0% |